Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2024-12-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于完成董事、监事补选暨部分董事、监事离任的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the completion of board and supervisory committee member by-elections and the resignation of some directors and supervisors. It details the composition of the new board and supervisory committee, names of the newly elected members, and the resignation and departure of previous members. There is no financial data, no discussion of financial results, no audit information, no voting results from a general meeting, and no mention of dividends or capital changes. The document is clearly about changes in the company's board of directors and senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is 2450 characters, which is consistent with an announcement rather than a full report. Hence, the classification is MANG with high confidence.
2024-12-30 Chinese
2024年第二次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 second extraordinary shareholders meeting of 阳普医疗科技股份有限公司. It includes voting results on various board-related proposals such as removal and election of directors and supervisors, attendance details, and legal opinions confirming the validity of the meeting and votes. The content focuses on the outcomes of shareholder votes and changes in board composition rather than financial results or report publication. The document length is about 3015 characters, which is relatively short but contains substantive voting results and decisions. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting. Therefore, the correct classification is DVA with high confidence.
2024-12-30 Chinese
北京市中伦（广州）律师事务所关于阳普医疗科技股份有限公司2024年第二次临时股东会的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and procedural compliance of a company's 2024 second extraordinary shareholders' meeting. It details the convening, attendance, voting procedures, and results of the meeting. The document does not contain financial statements or management discussion of financial results but focuses on the legal validation of the shareholders' meeting process and outcomes. This type of document is a legal proceedings report related to corporate governance and shareholder meetings, not an annual report, earnings release, or proxy solicitation. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is about 4934 characters, which is sufficient for a detailed legal opinion but not a full financial report.
2024-12-30 Chinese
关于召开2024年第二次临时股东会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2024 second extraordinary general meeting of shareholders for 阳普医疗科技股份有限公司. It includes information about the meeting date, voting procedures, proposals to be voted on, registration details, and proxy forms. There is no financial data or report content; rather, it is a notice informing shareholders about the meeting and how to participate and vote. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA) or a Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting and voting procedures before the meeting, it aligns more with Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is not a report of voting results (which would be DVA). Therefore, the correct classification is PSI.
2024-12-26 Chinese
第六届董事会第十一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at the 11th meeting of the 6th Board of Directors of Yangpu Medical Technology Co., Ltd. It details board member resignations, nominations for new directors, and the proposal to convene a shareholders' meeting to approve these changes. The content focuses on board and management changes, including director resignations and nominations, and the scheduling of a shareholders' meeting for approval. There are no financial statements, earnings data, or audit information. The document is not a report but an announcement of board/management changes. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 2167 characters, which is consistent with an announcement rather than a full report.
2024-12-12 Chinese
独立董事候选人声明与承诺
Board/Management Information Classification · 95% confidence The document is a formal declaration and commitment statement by an independent director candidate for a company's board. It details the candidate's qualifications, compliance with relevant laws and regulations, and commitments related to the role of an independent director. There are no financial statements, earnings data, or report summaries present. The document is not an announcement of voting results or a proxy solicitation but rather a regulatory compliance statement related to board management. Given the nature of the content focusing on board candidate qualifications and declarations, the most appropriate classification is Board/Management Information (MANG). The document length is 4419 characters, which is consistent with a detailed declaration rather than a brief announcement or a full report.
2024-12-12 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.